A Look Ahead: ALX Oncology Holdings's Earnings Forecast

ALX Oncology Holdings (NASDAQ:ALXO) is gearing up to announce its quarterly earnings on Friday, 2026-02-27. Here's a quick overview of what investors should know before the release.

Analysts are estimating that ALX Oncology Holdings will report an earnings per share (EPS) of $-0.34.

Investors in ALX Oncology Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

In the previous earnings release, the company beat EPS by $0.01, leading to a 0.0% drop in the share price the following trading session.

Here's a look at ALX Oncology Holdings's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.37	-0.37	-0.340	-0.39
EPS Actual	-0.36	-0.44	-0.477	-0.44
Price Change %	16.95	7.40	-8.240	-19.08

Performance of ALX Oncology Holdings Shares

Shares of ALX Oncology Holdings were trading at $2.42 as of February 25. Over the last 52-week period, shares are up 106.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for ALX Oncology Holdings visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.